跳至主要内容
临床试验/NCT06188234
NCT06188234招募中不适用

Observational Study on the Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab in Korean Type 2 Diabetes Mellitus Patients

Hanlim Pharm. Co., Ltd.1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2022年12月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
1
主要终点
Change in HbA1c at 6 months of prescribing Tenero Tablet/Tenero Emextended Release Tablet compared to baseline

研究概览

简要总结

This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinical practice.

详细描述

This study is to observe the clinical efficacy by analyzing the prescription patterns in routine clinical practice and changes in HbA1c, FPG, PP2G, etc., of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment. Additionally, the study intends to assess patient satisfaction based on these observations.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults over 19 years of age
  • Individuals diagnosed with type 2 diabetes.
  • Individuals who, at the clinical discretion, are prescribed Tenero Tab or Tenero M SR Tab for the purpose of diabetes treatment for the first time.
  • Individuals who have voluntarily provided written consent to participate in this study.

排除标准

  • Pregnant or breastfeeding women.
  • Individuals who are contraindicated according to the approved indications of Tenero Tab/Tenero M SR Tab.
  • Other cases where the principal investigator and study personnel deem individuals ineligible for participation in this clinical trial.

结局指标

主要结局

Change in HbA1c at 6 months of prescribing Tenero Tablet/Tenero Emextended Release Tablet compared to baseline

时间窗: after 6 months of prescription for Tenero Tab/Tenero M SR Tab compared to baseline

Change in HbA1c at 6 months of prescribing Tenero Tablet/Tenero Emextended Release Tablet compared to baseline

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验